查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1866972

腹部縫合系統市場按產品類型、材料、應用、最終用戶和分銷管道分類－2025-2032年全球預測

Abdominal Closure System Market by Product Type, Material, Application, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，腹部縫合系統市場規模將達到 3.4654 億美元，複合年成長率為 8.96%。

關鍵市場統計數據
基準年 2024 1.7439億美元
預計年份：2025年 1.9036億美元
預測年份 2032 3.4654億美元
複合年成長率 (%) 8.96%

腹部縫合系統全面介紹：概述其臨床重要性、技術發展歷程、相關人員的角色以及手術安全重點。

腹部縫合系統領域處於外科技術、材料科學和醫療設備工程的關鍵交叉點，即使是微小的進步也能直接轉化為病患預後的改善。本文闡述了臨床上對可靠、可重複的腹部縫合解決方案的需求，並概述了推動產品發展的關鍵技術趨勢。透過將醫療設備創新與不斷變化的手術技術偏好以及對手術全期安全性的日益重視相結合，本文為臨床、監管和商業相關人員相關者的策略決策提供了背景。

與不斷發展的臨床實踐模式一致，本導論部分重點闡述了黏合劑、固定系統、網片設計和縫合技術的逐步改進如何有助於降低併發症發生率、縮短手術時間並促進可預測的術後恢復。此外，本部分還著重強調了外科醫生、材料科學家和供應鏈專家之間的跨學科合作在將實驗室成果轉化為手術室可用產品方面所發揮的重要作用。最後，本部分闡明了影響產品推廣應用週期的典型利益相關人員優先事項，包括安全性、易用性、與不同手術流程的兼容性以及明確的報銷或採購理由，從而為後續的深入分析章節奠定基礎。

生物材料創新、器械改進、手術偏好轉變以及一體化手術模式的推動，正促使腹部縫合技術發生變革性轉變。

腹部縫合系統的模式正在發生變化，這得益於技術進步、臨床實踐的改變以及採購模式的演變。生物材料的創新正在研發出具有更高生物相容性和可客製化分解特性的黏合劑和網片，而器械的小型化和符合人體工學的設計則提高了易用性和手術速度。同時，臨床醫師的偏好正轉向能夠縮短手術時間和降低併發症風險的解決方案，這促使研發人員更加重視簡化工作流程和提升系統級整合價值。

此外，跨學科合作正在推動生物材料與合成材料相結合的混合解決方案的開發，以平衡生物完整性和機械強度。監管路徑和上市後監測要求也在不斷調整以適應新的器械和材料組合，這加大了製造商證明其長期安全性和性能的壓力。從商業性角度來看，隨著供應商尋求更靈活的採購方式，分銷和合約模式也在不斷演變，數位化採購管道正在拓展傳統直銷關係之外的管道。這些變化不僅改變了產品藍圖，也重塑了臨床證據的生成、檢驗和應用方式，從而改變了支持產品推廣的方式。

分析2025年美國關稅對供應鏈、零件採購、採購流程和醫院採購的累積影響

2025年美國關稅的累積影響，為腹部縫合系統生態系統的供應鏈設計、零件採購和採購行為帶來了新的轉折點。影響進口原料、聚合物組件和成品器械的關稅，提高了投入集中風險的可見度，促使製造商重新評估其採購基礎，並加快對替代供應商的資格認證。實際上，這意味著對器械組件關稅分類的審查力度加大，海關合規活動增多，以及對國際供應商網路中的到岸成本進行更積極的管理。

對於醫院和門診中心而言，下游影響正透過採購週期逐漸顯現。採購部門越來越關注總體擁有成本 (TCO) 和合約條款，以便將增加的投入成本轉嫁給客戶。他們也越來越重視零件來源的透明度，優先考慮那些能夠展現強大物流和本地組裝能力的供應商。同時，醫療設備製造商的創新團隊正在重新評估設計方案，以期透過材料替代來降低關稅風險，同時又不影響臨床效能。

為了因應關稅環境，相關人員正在實施各種緩解措施。製造商正在評估近岸外包方案並實現採購多元化，以減少對單一供應商的依賴。合約條款正在修訂，以便與買方分擔風險；庫存管理方式也在調整，以平衡營運資金和供應連續性。在監管方面，產品團隊正在評估組件變更對監管申報和上市後義務的影響，確保在材料替代或生產轉移的情況下，產品的安全性和有效性能夠保持一致。

最終，關稅環境凸顯了供應鏈敏捷性、監管前瞻性和商業性透明度的戰略重要性。這些因素共同加速了務實的供應鏈網路重組，強化了對供應商選擇的關注，並提升了在動盪的貿易環境中能夠提供穩定供應和可預測總採購成本的產品的價值。

細分市場分析洞察：揭示產品類型、生物材料、臨床應用、終端用戶和分銷管道如何相互交織，進而影響消費者選擇。

細分市場分析提供了觀點，幫助我們了解臨床需求、材料科學和採購管道如何相互交織，共同影響產品的開發和應用。按產品類型分類，腹部縫合解決方案涵蓋了黏合劑、夾子、網片系統、縫合釘和縫線，每種類別都有其獨特的臨床和商業性考慮。黏合劑分為纖維蛋白膠和組織黏合劑，分別針對不同的創傷治療生物學和應用技術。夾子有金屬和聚合物兩種材質，選擇時滲透性、生物相容性和成本。網片系統分為生物網片和合成網片。生物網膜來自牛或豬的組織，而合成網片通常由聚酯或聚丙烯製成，每種材料在宿主整合性和拉伸性能方面各有不同。縫合釘有手動和電動兩種類型，分別體現了對手術效率和易用性的偏好。縫線有可吸收和不可吸收兩種材質。可吸收縫線通常由聚乳酸-羥基Polyglactin910 或Polyglycolic乙醇酸製成，而不可吸收縫線則包括尼龍和聚丙烯，選擇取決於所需的持續時間和組織反應。

基於材料的分類進一步明確了臨床權衡。膠原蛋白和豬細胞外基質等生物材料因其組織重塑的潛力和在污染環境中的相容性而備受重視，而聚酯和聚丙烯等合成材料則提供可預測的機械強度和長期耐久性。基於應用的分類突顯了心血管外科、一般外科、婦科和整形外科之間需求的差異，每種外科手術都有獨特的機械負荷和感染風險。最終用戶（門診手術中心、醫院、專科診所）的觀點會影響產品選擇、購買頻率和服務預期。門診手術中心分為獨立門診手術中心和醫院附設門診手術中心，醫院分為私立醫院和公立醫院。專科診所傾向於尋求具有專業支援方案的利基解決方案。分銷管道（直銷、分銷商、線上平台）影響著商業性覆蓋範圍和定價策略，並決定培訓、循證傳播和售後支援的提供方式。整合這些細分維度，可以讓相關人員確定特定產品與臨床要求、採購慣例和分銷現實的契合點，從而為開發重點和上市定位提供資訊。

深入分析美洲、歐洲、中東和非洲以及亞太地區的區域狀況，重點在於供應鏈韌性、臨床應用模式和監管差異。

區域趨勢將顯著影響腹部縫合系統的臨床應用路徑、監管互動和供應鏈設計。在美洲，完善的採購流程和採購集團的整合帶來了規模經濟效益，同時也要求強而有力的臨床證據和整體成本優勢。該地區公立和私立醫療機構並存的格局，凸顯了能夠適應不同合約週期和基於價值的討論的商業模式的重要性。在歐洲、中東和非洲（EMEA），複雜的監管體系和多樣化的醫療資金籌措模式要求採取適應性強的監管策略和靈活的商業性方法，以兼顧各國的報銷體系和不同的臨床實踐規範。在許多EMEA市場，當地的註冊要求和公共採購流程會影響產品的推廣應用時間，因此與各國意見領袖進行有針對性的溝通至關重要。

在亞太地區，部分地區臨床應用迅速普及，而其他地區則對成本採購高度敏感，這促使製造商尋求分級產品組合和與區域成本結構相符的製造地。亞太地區多個司法管轄區的監管現代化為創新醫療材料鋪平了道路，但標準的差異仍然需要客製化的監管申報和區域特定的臨床數據。供應鏈考量因地區而異。原料產地的接近性、區域生產能力和物流基礎設施決定了前置作業時間和庫存策略。對於國際供應商而言，區域監管的多樣性和不同的臨床偏好意味著「一刀切」的方法很少奏效。要實現持續的市場滲透，需要差異化的產品系列、靈活的定價結構和區域特定的臨床證據包。總而言之，區域洞察凸顯了將監管計劃、生產策略和商業性執行與美洲、歐洲、中東和非洲以及亞太地區的獨特需求相匹配的必要性。

公司洞察，著重展現競爭優勢、產品系列、策略聯盟、研發重點和打入市場策略，進而推動其領導力發展。

腹部縫合領域的企業透過豐富的產品組合、材料專業知識和策略性的商業性關係來脫穎而出。業界領導者優先考慮研發投入，以開發更先進的生物材料和器械配置，從而減輕醫護人員的負擔，同時維持並改善臨床療效。與契約製造、學術機構和臨床網路建立夥伴關係和合作對於加速研發週期和獲得可靠的臨床檢驗至關重要。擁有多元化產品系列（包括黏合劑、網片、縫合釘和縫合系統）的企業在提供整合解決方案、滿足不同外科專科的需求以及佔據醫院採購平台更大佔有率方面具有優勢。

競爭定位也受到市場進入模式的影響。將直銷活動與經銷商關係和數位化管道結合的公司，能夠觸及更廣泛的終端用戶，同時提供靈活的商業條款，以滿足不同機構的採購偏好，包括獨立和醫院附屬的門診手術中心、私立和公立醫院以及專科診所。附加價值服務，例如外科醫生培訓計畫、臨床資料儲存庫和捆綁式合約選項，能夠加強客戶關係並提高轉換成本。此外，那些建立健全的品管系統和透明供應鏈可追溯性的公司，正受到採購部門的優先考慮，因為他們需要確保供應的審核和連續性。併購仍是獲取新型生物材料專業知識、拓展地域覆蓋範圍以及加速進入鄰近手術領域的有效途徑。這些策略選擇共同塑造了競爭格局，在這個格局中，技術卓越、商業性適應性和實證實踐決定了市場領導地位。

為領導者提供切實可行的建議，以加速創新、加強供應鏈、簡化採購流程，並將臨床重點與商業性執行結合。

腹部縫合領域的領導企業應採取一系列切實可行、注重營運的措施，將洞見轉化為可衡量的優勢。首先，優先投資於生物材料研究，重點在於生物完整性和機械性能的平衡。與臨床合作夥伴進行協作式試驗設計將提高研究的相關性並加速其應用。其次，實現供應商關係多元化，並考慮近岸外包或雙重採購策略，以降低對單一地區的依賴，並減少關稅和物流的意外風險。第三，透過整合培訓、臨床結果數據以及符合醫院價值導向採購要求的捆綁式產品和服務，增強商業性提案。

同時，製造商和供應商應更新採購框架，並專注於整體擁有成本、供應透明度和可預測的前置作業時間。納入允許成本分攤和明確價格上漲條款的合約機制，可以減少投入價格波動帶來的摩擦。加強監管準備至關重要：任何材料替代或生產轉移都應事先進行嚴格的等效性測試並與監管機構協商，以避免上市後出現問題。最後，考慮實施數位化工具，透過實踐培訓、證據摘要和真實世界性能數據來促進臨床醫生的參與，並收集結果以推動產品持續改進。全面實施這些措施將增強韌性，促進順利推廣，並確保永續的商業性績效。

調查方法摘要，涵蓋研究設計、一手和二手資料收集、專家訪談、檢驗以及證據綜合分析方法。

本研究設計結合了質性研究和全面的二手資料綜合分析，建構了多層次的證據基礎。主要活動包括：對循環系統、一般外科、婦科和整形外科醫生進行結構化訪談；與門診手術中心和醫院的採購和供應鏈經理進行深入討論；以及諮詢監管機構和生產專家，以了解材料來源和合規性方面的考慮。二手研究納入了同行評審文獻、監管指導文件以及已發布的生物材料和手術結果技術規範，以更好地闡釋主要研究的發現。

分析方法強調檢驗和檢驗。訪談結果經過主題編碼，並與二級資訊來源交叉比對，以識別趨同趨勢並發現需要進一步調查的差異。透過供應鏈映射和組件採購分析，揭示集中風險並評估潛在的緩解策略。檢驗過程透過與外部專家進行多次迭代審查以及與監管先例交叉比對，確保技術表徵的準確性。這種方法將定性分析的深度與系統檢驗相結合，從而得出可靠且可操作的結論，適用於商業性和臨床決策。

總之，我們綜合了關鍵的臨床、技術、監管和商業性見解，以指導腹部縫合領域的策略決策和未來重點工作。

最終的綜合分析將臨床需求、材料科學發展、供應鏈現狀和商業策略融會貫通，形成一套連貫的結論，以指南未來的行動。在所有產品類型中，材料選擇和器械人體工學設計仍然是改善手術效果和加速臨床接受度的關鍵因素。關稅和貿易環境為策略規劃增添了新的維度，使得增強供應鏈韌性和供應商多元化成為優先事項。美洲、歐洲、中東和非洲以及亞太地區的區域差異需要製定細緻的監管計劃和差異化的商業化策略，以滿足當地的市場需求。

那些將嚴謹的研發投入、透明的供應鏈運作和靈活的商業模式結合的公司，將更有能力滿足醫療服務提供者的需求並維持長期合作關係。醫療服務提供者和採購團隊應尋求能夠提供可預測的供應、清晰的臨床證據和靈活的合約選擇的夥伴關係。簡而言之，事實證明，一種平衡的方法行之有效，該方法能夠同時推動創新、增強營運韌性，並實現符合外科團隊和醫療系統採購人員實際需求的商業性執行。這種綜合觀點為優先考慮能夠帶來持續臨床和商業性效益的措施提供了切實可行的基礎。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 腹部手術中擴大採用帶倒刺縫合技術進行快速可靠的筋膜縫合
  • 增加抗菌和防沾黏網片材料的使用，以減少術後感染和沾黏的形成。
  • 機器人輔助腹壁縫合系統的普及提高了手術精度並減輕了外科醫生的疲勞。
  • 推出配備感應器的傷口閉合裝置，可即時監測傷口張力，進而創傷治療。
  • 醫院感染控制通訊協定和成本分析推動了一次性腹部縫合套件的過渡。
  • 可吸收倒刺縫合線逐漸取代傳統的編織縫合線，提高了腹腔鏡縫合的效率。
  • 創新閉合系統獲得更廣泛的監管核准，加速進入亞太和拉丁美洲市場

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依產品類型分類的腹部縫合系統市場

  • 黏合式封口
    • 纖維蛋白膠
    • 組織黏合劑
  • 夾子
    • 金屬夾
    • 聚合物夾
  • 網格系統
    • 生物網膜
      • 牛源
      • 源自豬
    • 合成網
      • 聚酯纖維
      • 聚丙烯
  • 史泰博
    • 手動輸入
    • 電的
  • 縫合線
    • 吸收性
      • Polyglactin910
      • Polyglycolic
    • 不可吸收
      • 尼龍
      • 聚丙烯

9. 按材料分類的腹部縫合系統市場

  • 生物來源
    • 膠原蛋白
    • 豬源性細胞外基質
  • 合成
    • 聚酯纖維
    • 聚丙烯

第10章 依應用分類的腹部閉合系統市場

  • 心血管外科
  • 一般外科
  • 婦科手術
  • 整形外科手術

第11章 腹部縫合系統市場（依最終用戶分類）

  • 門診手術中心
    • 獨立的
    • 醫院附屬機構
  • 醫院
    • 私人的
    • 民眾
  • 專科診所

第12章 腹部縫合系統市場（依分銷管道分類）

  • 直銷
  • 經銷商
  • 線上平台

13. 各地區腹部縫合系統市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 腹部閉合系統市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國腹部縫合系統市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Johnson & Johnson
    • Medtronic plc
    • B. Braun Melsungen AG
    • 3M Company
    • Cardinal Health, Inc.
    • Smith & Nephew plc
    • Stryker Corporation
    • CONMED Corporation
    • Teleflex Incorporated
    • Baxter International Inc.
Product Code: MRR-CD5A9334D821

The Abdominal Closure System Market is projected to grow by USD 346.54 million at a CAGR of 8.96% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 174.39 million
Estimated Year [2025] USD 190.36 million
Forecast Year [2032] USD 346.54 million
CAGR (%) 8.96%

Comprehensive introduction to abdominal closure systems outlining clinical importance, technology evolution, stakeholder roles, and priorities for surgical safety

The abdominal closure system landscape occupies a critical intersection of surgical technique, material science, and device engineering, where small advances translate directly into improved patient outcomes. This introduction frames the clinical imperative for reliable, reproducible abdominal closure solutions while outlining the major technology vectors that are driving product evolution. By situating device innovation alongside changing procedural preferences and heightened emphasis on perioperative safety, the narrative establishes the context for strategic decision-making across clinical, regulatory, and commercial stakeholders.

To maintain coherence with evolving practice patterns, the introduction emphasizes how incremental improvements in adhesives, fastening systems, mesh design, and suture technology can reduce complication rates, shorten operative time, and contribute to more predictable postoperative recovery. It also highlights the role of multidisciplinary collaboration-between surgeons, materials scientists, and supply chain professionals-in translating laboratory advances into usable products in the operating room. Finally, the section clarifies the stakeholder priorities that typically govern adoption cycles, including demonstrable safety, ease of use, compatibility with diverse surgical workflows, and clarity in reimbursement or purchasing rationale, setting the stage for deeper analytical sections that follow.

Transformative shifts in abdominal closure driven by biomaterials innovation, device refinement, procedural preference evolution, and integrated surgical models

The landscape for abdominal closure systems is shifting under a confluence of technological progress, clinical practice changes, and evolving procurement models. Biomaterials innovation is unlocking adhesives and meshes with enhanced biocompatibility and tailored degradation profiles, while device miniaturization and ergonomics are improving handling and procedural speed. Concurrently, clinician-led preferences are moving toward solutions that reduce operating room time and lower complication risk, prompting developers to place greater emphasis on simplified workflows and integrated system-level value.

In addition, cross-disciplinary collaborations are fostering hybrid solutions that blend biologic and synthetic approaches to balance host integration and mechanical strength. Regulatory pathways and post-market surveillance requirements are also adapting to novel device-material combinations, exerting greater pressure on manufacturers to demonstrate long-term safety and performance. From a commercial perspective, distribution and contracting models are evolving as providers seek more flexible sourcing options and as digital procurement channels expand access beyond traditional direct-sales relationships. Taken together, these shifts are not only altering product roadmaps but are also reshaping how clinical evidence is generated, validated, and deployed to support adoption.

Analysis of the cumulative impact of United States tariff actions in 2025 on supply chains, component sourcing, procurement approaches, and hospital procurement

The cumulative impact of United States tariff actions in 2025 has introduced new inflection points for supply chain design, component sourcing, and procurement behaviour across the abdominal closure ecosystem. Tariff measures affecting imported raw materials, polymer components, and finished devices have increased the visibility of input-concentration risk, prompting manufacturers to re-evaluate sourcing footprints and to accelerate qualification of alternate suppliers. In practice, this has meant closer scrutiny of tariff classifications for device components, increased customs compliance activity, and more active management of landed costs across international supplier networks.

Hospitals and ambulatory centers have felt the downstream effects through procurement cycles, with purchasing teams increasingly focused on total cost of ownership and on contract terms that allow pass-through of increased input costs. Providers are also more likely to request greater transparency on component origin and to favor suppliers that can demonstrate resilient logistics or local assembly capabilities. Meanwhile, innovation teams at device manufacturers are reassessing design choices where material substitution could mitigate tariff exposure without compromising clinical performance.

To navigate the tariff environment, stakeholders are implementing a range of mitigation strategies. Manufacturers are evaluating nearshoring options and diversifying supplier bases to reduce single-source dependencies. Contractual terms are being revised to share risk with buyers, and inventory management practices are being adjusted to balance working capital with supply continuity. On the regulatory side, product teams are weighing the implications of component changes on regulatory filings and post-market obligations, ensuring that any material substitutions or manufacturing transfers retain equivalence in safety and effectiveness.

Ultimately, the tariff context has reinforced the strategic importance of supply chain agility, regulatory foresight, and commercial transparency. The combined effect has been an acceleration in practical supply network redesign, a renewed focus on supplier qualification, and an increased premium on products that can demonstrate consistent availability and predictable total acquiring costs under shifting trade conditions.

Segmentation insights exploring how product categories, biomaterials, clinical applications, end users, and distribution channels converge to shape selection

Segmentation analysis offers a lens to understand how clinical needs, material science, and purchasing channels intersect to shape product development and adoption. When viewed by product type, the universe of abdominal closure solutions spans adhesive closures, clips, mesh systems, staples, and sutures, with each category bringing distinct clinical and commercial considerations. Adhesive closures divide into fibrin sealants and tissue adhesives, which cater to different wound-healing biology and application techniques. Clips are available in metal and polymer variants, where the choice often balances radiopacity, biocompatibility, and cost. Mesh systems bifurcate into biological and synthetic options; biological meshes can be sourced from bovine or porcine tissues, while synthetic meshes are typically polyester or polypropylene, each material offering a different profile for host integration and tensile properties. Staples arrive as manual and powered formats, reflecting preferences for procedural efficiency and ergonomics. Sutures present choices between absorbable and nonabsorbable materials; absorbable threads are often polyglactin 910 or polyglycolic acid, while nonabsorbable options include nylon and polypropylene, decisions that hinge on desired longevity and tissue response.

Material-based segmentation further clarifies clinical trade-offs. Biological materials such as collagen and porcine extracellular matrix are valued for their remodelling potential and compatibility with contaminated fields, whereas synthetic options like polyester and polypropylene provide predictable mechanical strength and long-term durability. Application-driven segmentation highlights divergence in requirement sets across cardiovascular, general, gynecological, and orthopedic surgery, with each area imposing unique mechanical demands and infection-risk profiles. The end-user perspective, spanning ambulatory surgical centers, hospitals, and specialty clinics, influences product selection, purchasing cadence, and service expectations; ambulatory surgical centers include freestanding and hospital-affiliated models, hospitals split between private and public ownership, and specialty clinics often seek niche solutions with focused support packages. Distribution channels-direct sales, distributors, and online platforms-shape commercial reach and pricing dynamics and determine how training, evidence dissemination, and post-sale support are delivered. By synthesizing these segmentation dimensions, stakeholders can identify where a given product aligns with clinical requirements, procurement practices, and distribution realities, thereby informing development priorities and go-to-market positioning.

Regional insights for the Americas, EMEA, and Asia-Pacific emphasizing supply chain resilience, clinical adoption patterns, and regulatory differences

Regional dynamics exert substantial influence on clinical adoption pathways, regulatory interactions, and supply chain design for abdominal closure systems. In the Americas, procurement sophistication and consolidated purchasing groups create both opportunities for scale and pressures for robust clinical evidence and favorable total cost narratives. The region's mix of private and public providers places a premium on commercial models that can accommodate varied contracting cycles and value-based discussions. Europe, Middle East & Africa presents a complex regulatory mosaic and heterogeneous healthcare financing models, demanding adaptable regulatory strategies and flexible commercial approaches that account for national reimbursement schemes and differing clinical practice norms. In many EMEA markets, local registration requirements and public procurement processes shape time-to-adoption and necessitate targeted engagement with national opinion leaders.

Asia-Pacific offers a combination of rapid clinical adoption in certain hubs and cost-sensitive procurement in others, driving manufacturers to pursue tiered product offerings and manufacturing footprints that address regional cost structures. Across Asia-Pacific, regulatory modernization in several jurisdictions has opened pathways for innovative materials, but variability in standards still requires tailored regulatory dossiers and localized clinical data. Supply chain considerations vary across regions: proximity to raw material sources, regional manufacturing capabilities, and logistics infrastructure determine lead times and inventory strategies. For international suppliers, regional regulatory heterogeneity and differing clinical preferences mean that a one-size-fits-all approach is rarely effective; instead, differentiated portfolios, flexible pricing constructs, and region-specific clinical evidence packages are required to achieve sustainable penetration. Overall, regional insights underscore the necessity of aligning regulatory planning, manufacturing strategy, and commercial execution with the unique demands of the Americas, Europe, Middle East & Africa, and Asia-Pacific.

Company insights highlighting competitive positioning, product portfolios, strategic alliances, R&D priorities, and go-to-market strategies that drive leadership

Companies operating in the abdominal closure domain are distinguishing themselves through a blend of portfolio depth, materials expertise, and strategic commercial relationships. Industry leaders prioritize investments in R&D to refine biomaterials and to develop device configurations that reduce clinician burden while preserving or enhancing clinical outcomes. Partnerships and alliances-whether with contract manufacturers, academic centers, or clinical networks-have become central to accelerating development cycles and gaining credible clinical validation. Firms with diversified product portfolios that span adhesives, meshes, staples, and suture systems are better positioned to provide bundled solutions, address cross-surgical needs, and capture a larger share of hospital purchasing frameworks.

Competitive positioning is also shaped by go-to-market models. Companies that combine direct-sales engagement with distributor relationships and digital channels can reach a broader set of end users while tailoring commercial terms to account for the purchasing preferences of freestanding ambulatory surgical centers, hospital-affiliated ASCs, private and public hospitals, and specialty clinics. Value-added services-such as surgeon training programs, clinical data repositories, and bundled contracting options-strengthen customer relationships and create higher switching costs. Additionally, firms that cultivate robust quality systems and transparent supply-chain traceability are gaining preference among procurement teams that demand auditability and continuity of supply. Mergers and acquisitions continue to be tools for acquiring novel biomaterials expertise, expanding geographic reach, and accelerating entry into adjacent procedural areas. Taken together, these strategic choices define a competitive landscape where technical excellence, commercial adaptability, and evidence-based engagement determine market leadership.

Practical recommendations enabling leaders to accelerate innovation, strengthen supply chains, streamline procurement, and synchronize clinical priorities with commercial execution

Leaders in the abdominal closure sector should adopt a set of pragmatic, operationally focused actions to translate insight into measurable advantage. First, prioritize targeted investment in biomaterials research that balances host integration with mechanical performance; working with clinical partners to co-design trials will increase relevance and accelerate adoption. Second, diversify supplier relationships and consider nearshoring or dual-sourcing strategies to reduce dependency on single geographies and to mitigate tariff or logistics shocks. Third, strengthen commercial propositions by integrating training, clinical outcomes data, and bundled offerings that align with hospital value-based purchasing requirements.

In parallel, manufacturers and providers should modernize procurement frameworks to emphasize total cost of ownership, supply transparency, and predictable lead times. Embedding contractual mechanisms that allow for cost-sharing and clear escalation clauses will reduce friction when input prices shift. Regulatory readiness must be elevated: any material substitutions or manufacturing transfers should be preceded by rigorous equivalence testing and regulatory consultation to avert post-market complications. Finally, invest in clinician engagement by providing hands-on training, evidence summaries, and real-world performance data, and consider digital tools to capture outcomes and inform iterative product improvements. These actions, taken together, will enhance resilience, facilitate smoother adoption, and support sustainable commercial performance.

Methodology summary covering research design, primary and secondary data collection, expert interviews, validation, and analytic methods for evidence synthesis

The research design combined primary qualitative inquiry with comprehensive secondary synthesis to produce a multilayered evidence base. Primary activities included structured interviews with clinicians across cardiovascular, general, gynecological, and orthopedic specialties, in-depth discussions with procurement and supply chain leaders from ambulatory surgical centers and hospitals, and consults with regulatory and manufacturing experts to understand material sourcing and compliance considerations. Secondary research incorporated peer-reviewed literature on biomaterials and surgical outcomes, regulatory guidance documents, and publicly available technical specifications to contextualize primary insights.

Analytic techniques emphasized triangulation and validation. Interview findings were coded thematically and cross-referenced with secondary sources to identify convergent signals and to expose areas of divergence requiring further inquiry. Supply chain mapping and component provenance analysis were employed to uncover concentration risks and to evaluate potential mitigation pathways. Validation steps included iterative review sessions with external subject matter experts and cross-checks against regulatory precedents to ensure the accuracy of technical characterizations. The approach balanced qualitative depth with systematic verification to produce robust, actionable insights suitable for commercial and clinical decision-making.

Conclusion synthesizing key clinical, technological, regulatory, and commercial insights to guide strategic decisions and future priorities in abdominal closure

The concluding synthesis brings together clinical imperatives, material science developments, supply chain realities, and commercial strategy into a coherent set of insights to inform next steps. Across product categories, materials choices and device ergonomics remain primary levers for improving surgical outcomes and accelerating clinical acceptance. The tariff and trade environment has added a new dimension to strategic planning, elevating supply chain resilience and supplier diversification as priority initiatives. Regional heterogeneity-spanning the Americas, Europe, Middle East & Africa, and Asia-Pacific-requires nuanced regulatory planning and differentiated commercialization strategies to match local adoption drivers.

Companies that combine disciplined R&D investment, transparent supply chain practices, and adaptive commercial models will be best positioned to meet provider needs and to sustain long-term engagement. Providers and procurement teams, for their part, should seek partnerships that offer predictable supply, clear clinical evidence, and flexible contracting options. In sum, the evidence supports a balanced approach that simultaneously advances technical innovation, strengthens operational resilience, and aligns commercial execution with the practical demands of surgical teams and health system purchasers. This integrated perspective provides a pragmatic foundation for prioritizing initiatives that will yield durable clinical and commercial benefits.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of barbed suture technology for faster secure fascial closure in abdominal procedures
  • 5.2. Increasing integration of antimicrobial and antiadhesion mesh materials to reduce postoperative infections and adhesions
  • 5.3. Surge in robotic assisted abdominal wall closure systems improving precision and reducing surgeon fatigue
  • 5.4. Emergence of sensor enabled closure devices offering real time wound tension monitoring for enhanced healing outcomes
  • 5.5. Shift toward single use disposable abdominal closure kits driven by hospital infection control protocols and cost analysis
  • 5.6. Growing preference for absorbable barbed sutures over traditional braided materials to streamline laparoscopic closures
  • 5.7. Expanding regulatory approvals for innovative closure systems facilitating market entry in Asia Pacific and Latin America

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Abdominal Closure System Market, by Product Type

  • 8.1. Adhesive Closures
    • 8.1.1. Fibrin Sealants
    • 8.1.2. Tissue Adhesive
  • 8.2. Clips
    • 8.2.1. Metal Clips
    • 8.2.2. Polymer Clips
  • 8.3. Mesh Systems
    • 8.3.1. Biological Mesh
      • 8.3.1.1. Bovine
      • 8.3.1.2. Porcine
    • 8.3.2. Synthetic Mesh
      • 8.3.2.1. Polyester
      • 8.3.2.2. Polypropylene
  • 8.4. Staples
    • 8.4.1. Manual
    • 8.4.2. Powered
  • 8.5. Sutures
    • 8.5.1. Absorbable
      • 8.5.1.1. Polyglactin 910
      • 8.5.1.2. Polyglycolic Acid
    • 8.5.2. Nonabsorbable
      • 8.5.2.1. Nylon
      • 8.5.2.2. Polypropylene

9. Abdominal Closure System Market, by Material

  • 9.1. Biological
    • 9.1.1. Collagen
    • 9.1.2. Porcine Extracellular Matrix
  • 9.2. Synthetic
    • 9.2.1. Polyester
    • 9.2.2. Polypropylene

10. Abdominal Closure System Market, by Application

  • 10.1. Cardiovascular Surgery
  • 10.2. General Surgery
  • 10.3. Gynecological Surgery
  • 10.4. Orthopedic Surgery

11. Abdominal Closure System Market, by End User

  • 11.1. Ambulatory Surgical Centers
    • 11.1.1. Freestanding
    • 11.1.2. Hospital-Affiliated
  • 11.2. Hospitals
    • 11.2.1. Private
    • 11.2.2. Public
  • 11.3. Specialty Clinics

12. Abdominal Closure System Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online Platforms

13. Abdominal Closure System Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Abdominal Closure System Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Abdominal Closure System Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Johnson & Johnson
    • 16.3.2. Medtronic plc
    • 16.3.3. B. Braun Melsungen AG
    • 16.3.4. 3M Company
    • 16.3.5. Cardinal Health, Inc.
    • 16.3.6. Smith & Nephew plc
    • 16.3.7. Stryker Corporation
    • 16.3.8. CONMED Corporation
    • 16.3.9. Teleflex Incorporated
    • 16.3.10. Baxter International Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ABDOMINAL CLOSURE SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ABDOMINAL CLOSURE SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ABDOMINAL CLOSURE SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FIBRIN SEALANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FIBRIN SEALANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FIBRIN SEALANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FIBRIN SEALANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FIBRIN SEALANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FIBRIN SEALANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY TISSUE ADHESIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY TISSUE ADHESIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY TISSUE ADHESIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY TISSUE ADHESIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY TISSUE ADHESIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY TISSUE ADHESIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY METAL CLIPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY METAL CLIPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY METAL CLIPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY METAL CLIPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY METAL CLIPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY METAL CLIPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYMER CLIPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYMER CLIPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYMER CLIPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYMER CLIPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYMER CLIPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYMER CLIPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BOVINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BOVINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BOVINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BOVINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BOVINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BOVINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MANUAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MANUAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MANUAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MANUAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MANUAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POWERED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POWERED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POWERED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POWERED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POWERED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POWERED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLACTIN 910, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLACTIN 910, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLACTIN 910, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLACTIN 910, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLACTIN 910, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLACTIN 910, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NYLON, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NYLON, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NYLON, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NYLON, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NYLON, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NYLON, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COLLAGEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COLLAGEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COLLAGEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COLLAGEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COLLAGEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE EXTRACELLULAR MATRIX, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE EXTRACELLULAR MATRIX, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE EXTRACELLULAR MATRIX, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE EXTRACELLULAR MATRIX, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE EXTRACELLULAR MATRIX, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE EXTRACELLULAR MATRIX, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FREESTANDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FREESTANDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FREESTANDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FREESTANDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FREESTANDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FREESTANDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITAL-AFFILIATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITAL-AFFILIATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITAL-AFFILIATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITAL-AFFILIATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITAL-AFFILIATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITAL-AFFILIATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRIVATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRIVATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRIVATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PUBLIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PUBLIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PUBLIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PUBLIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ONLINE PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ONLINE PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ONLINE PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ONLINE PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 301. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 302. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 303. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2018-2024 (USD MILLION)
  • TABLE 306. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2025-2032 (USD MILLION)
  • TABLE 307. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2018-2024 (USD MILLION)
  • TABLE 308. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2025-2032 (USD MILLION)
  • TABLE 309. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 310. AMERICA